GGrantIndex
← Search

Flow Cytometry Shared Resource

$42,698P30FY2024CANIH

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

Linked publications, trials & patents

Trial NCT07614022Trial NCT07324577Trial NCT07322367Trial NCT07282444Trial NCT07203534Trial NCT07196241Trial NCT07175376Trial NCT07119489Trial NCT07046936Trial NCT06945042Trial NCT06709404Trial NCT06654245Trial NCT06480591Trial NCT06441266Trial NCT06340503Trial NCT05984680Trial NCT05934851Trial NCT05877404Trial NCT05854966Trial NCT05825066Trial NCT05796518Trial NCT05696782Trial NCT05692635Trial NCT05597878Trial NCT05395936Trial NCT05309655Trial NCT05242770Trial NCT05212272Trial NCT05204290Trial NCT05030038Trial NCT04897217Trial NCT04858269Trial NCT04797884Trial NCT04677816Trial NCT04659993Trial NCT04623515Trial NCT04586127Trial NCT04526080Trial NCT04495751Trial NCT04485026Trial NCT04454489Trial NCT04430335Trial NCT04415944Trial NCT04375384Trial NCT04337580Trial NCT04327700Trial NCT04266470Trial NCT04253964Trial NCT04217317Trial NCT04174742Trial NCT04173247Trial NCT04111107Trial NCT04040244Trial NCT04037527Trial NCT03998189Trial NCT03987568Trial NCT03987555Trial NCT03982537Trial NCT03963739Trial NCT03958747Trial NCT03929211Trial NCT03890614Trial NCT03880526Trial NCT03874065Trial NCT03870529Trial NCT03870451Trial NCT03868943Trial NCT03867175Trial NCT03861091Trial NCT03861065Trial NCT03796273Trial NCT03746262Trial NCT03741868Trial NCT03741829Trial NCT03740035Trial NCT03681405Trial NCT03662074Trial NCT03529565Trial NCT03520283Trial NCT03505762Trial NCT03505736Trial NCT03505671Trial NCT03379376Trial NCT03374995Trial NCT03370159Trial NCT03188432Trial NCT03152786Trial NCT03148080Trial NCT03139435Trial NCT03122743Trial NCT03087591Trial NCT03032250Trial NCT02971410Trial NCT02971397Trial NCT02949843Trial NCT02835222Trial NCT02835066Trial NCT02832154Trial NCT02827838Trial NCT02747407

Abstract

FLOW CYTOMETRY SHARED RESOURCE (FCSR): PROJECT SUMMARY The goal of the Flow Cytometry Shared Resource (FCSR) is to provide Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) members with ready access to the necessary expertise and state -of-the-art flow cytometry instrumentation that can be applied to a wide range of cancer biology research. Flow cytometry is a critical technology that provides rapid single-cell analysis and cell sorting through the simultaneous detection of light scatter properties and the presence of multiple cellular molecules or metabolites in or on an individual cell. In addition, the FCSR seeks to foster the development of protocols that can utilize the continually increasing number of available markers and methodologies. FCSR is focused on addressing the needs of both seasoned flow cytometry users as well as those just discovering the capabilities of flow cytometry tech nology. To this end, FCSR provides monthly training for the instruments for new users and offers support in experimental design and data interpretation following training. Over the current funding period, the FCSR significantly expanded capabilities through the addition of Fortessa and Astrios instruments. In October 2019, the FCSR was awarded an S10 shared instrumentation grant for purchasing a NanoCellect WOLF. Instruments available via the FCSR include a Beckman Coulter MoFlo Astrios (5 lasers and 25 parameters) sorter, a NanoCellect WOLF (1 laser and 5 parameters), a BD Fortessa X-20 (5 lasers and 20 parameters), a BD FACSCanto II analyzer (3 lasers and 10 parameters), a BD FACS Aria cell sorter (3 lasers and 11 parameters), a BD FACSCalibur, and a BD Accuri C6 analyzer (2 lasers and 6 parameters). In addition to the software with each flow cytometer, software is available to analyze multiparameter data to identify and characterize cell subpopulations. DNA histogram analysis software programs are also available for researchers requiring advanced cell cycle analysis. The FCSR is under the directorship of Jason M. Grayson, PhD and has a staff of 1.93 FTEs. To accomplish the goals of the facility, the FCSR has the following Specific Aims: (1) provide cutting-edge analysis instrumentation for flow cytometric analysis; (2) provide multi-parameter cell sorting for user-defined populations; (3) provide instrument training for new and existing users; and (4) provide expertise for experimental design and interpretation of flow cytometry data. From November 1, 2015 to October 16, 2020, the FCSR provided services to 85 users, 60 of whom were WFBCCC members, with 75% supported by peer-reviewed funding. FCSR services were used by investigators representing all four WFBCCC programs and have supported research for 44 grants, including 20 NCI-funded projects, and multiple DoD grants. In the current funding period, 79 publications reported research that utilized the FCSR, including 11 publications with an impact factor greater than 10.

View original record on NIH RePORTER →